Posted from: Monday, October 28, 2013 - 03:30 PM - Present

DRUG RECALL - Albuterol Sulfate Inhalation Solution 0.83% used for Treatment of Bronchospasms

October 10, 2013, Nephron Pharmaceuticals Corporation (NPC) issued a voluntary recall of Albuterol Sulfate Inhalation Solution 0.83% as a precautionary measure because the affected lots did not pass NPC’s quality testing.

Albuterol Sulfate Inhalation Solution 0.83% is used for the treatment of bronchospasms.

The ten affected lots of this recall are:

  1. A3A33A
  2. A3A33B
  3. A3A34A
  4. A3A35A
  5. A3A36A
  6. A3A37A
  7. A3A38A
  8. A3A40A
  9. A3A41A
  10. A3A42A
  11.  

If you have this product, it is suggested that you cease its use and return any remaining medication to your pharmacy. If you have any questions about this recall, please contact your local retail pharmacist or speak to your doctor.

Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail, or by fax:

Online - www.fda.gov/medwatch/report.htm

Regular Mail - use postage-paid FDA form 3500 available at www.fda.gov/MedWatch/getforms.htm. Mail the form to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787

Fax - 1-800-FDA-0178

Last Updated Thursday, March 23, 2017 - 07:11 AM.